의료 관련 주식
| # | 이전 7일 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2526 |  GERN Geron Corporation - Common Stock | 1.23 USD | +3.36% | +1.65% | -6.82% | +0.82% | 790.24 M USD | ||
| 2539 |  BBNX Beta Bionics, Inc. - Common Stock | 17.31 USD | +2.61% | -0.92% | -22.93% | -18.58% | 778.77 M USD | ||
| 2543 |  VREX Varex Imaging Corporation - Common Stock | 18.47 USD | +0.44% | -0.11% | -0.16% | +59.91% | 777.59 M USD | ||
| 2573 |  DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 11.74 USD | +1.82% | +0.09% | +62.38% | +32.21% | 755.35 M USD | ||
| 2575 |  COLL Collegium Pharmaceutical, Inc. - Common Stock | 23.18 USD | +2.98% | +5.32% | +3.67% | -34.04% | 754.64 M USD | ||
| 2584 |  SANA Sana Biotechnology, Inc. - Common Stock | 2.48 USD | +6.44% | -11.11% | -20.00% | -52.76% | 742.41 M USD | ||
| 2592 |  LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 1.65 USD | +3.12% | -5.71% | -18.32% | +14.58% | 734.18 M USD | ||
| 2604 |  ACHV Achieve Life Sciences, Inc. - Common Shares | 6.97 USD | -0.43% | -3.19% | -8.17% | +75.57% | 717.23 M USD | ||
| 2612 |  GYRE Gyre Therapeutics, Inc. - Common Stock | 6.40 USD | -1.08% | -5.88% | -5.88% | -22.52% | 713.66 M USD | ||
| 2614 |  FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 12.87 USD | +5.49% | +1.34% | -7.61% | +13.89% | 710.99 M USD | ||
| 2624 |  CTKB Cytek Biosciences, Inc. - Common Stock | 5.41 USD | +0.19% | +1.69% | +8.42% | +36.62% | 703.21 M USD | ||
| 2642 |  PHR Phreesia, Inc. Common Stock | 11.04 USD | +3.86% | +2.41% | +7.39% | -52.88% | 685.26 M USD | ||
| 2644 |  ANNX Annexon, Inc. - common stock | 3.60 USD | -1.91% | -9.32% | -8.16% | +14.65% | 682.48 M USD | ||
| 2646 |  MDXG MiMedx Group, Inc - Common Stock | 4.68 USD | -0.43% | +1.52% | -2.09% | -29.31% | 682.16 M USD | ||
| 2647 |  CADL Candel Therapeutics, Inc. - Common Stock | 8.91 USD | -1.76% | -8.05% | -19.07% | +66.85% | 681.78 M USD | ||
| 2654 |  PHAR Pharming Group N.V. - ADS, each representing 10 | 9.59 USD | -0.52% | -2.04% | -10.79% | -32.70% | 672.91 M USD | ||
| 2666 |  AURA Aura Biosciences, Inc. - Common Stock | 6.34 USD | +2.76% | -2.46% | -7.31% | +3.59% | 657.49 M USD | ||
| 2670 |  DSGN Design Therapeutics, Inc. - Common Stock | 10.48 USD | +7.71% | -8.63% | -17.67% | +69.58% | 655.86 M USD | ||
| 2671 |  PRME Prime Medicine, Inc. - Common Stock | 3.61 USD | +15.34% | 0.00% | +16.08% | -36.11% | 654.77 M USD | ||
| 2684 |  AVTX Avalo Therapeutics, Inc. - Common Stock | 12.01 USD | +1.44% | -10.51% | -29.23% | -13.60% | 644.10 M USD |
뉴스 의료 관련 주식
UBS, 솔리드 바이오사이언스 투자의견 ‘매수’로 신규 개시···목표주가 20달러 제시
매크로제닉스, 진행성 고형암 환자 대상 비공개 표적 항체-약물 접합체 MGC030의 1상 임상시험에서 첫 환자 투여
목요일 장중 변동한 12개 헬스케어 주식
다이애딕 인터내셔널 13G 공시: 엠퍼리 에셋 매니지먼트, 9월 30일 기준 8.35% 지분 보유 보고
뉴라시스, 의료 정책 적용 범위가 2,600만 명 이상의 의료 보험 가입자에게 확대되었다고 발표
에데사 바이오테크, 백반증 치료제 EB06의 2상 임상시험을 위한 신약 임상시험계획(IND) 신청에 대해 FDA 승인 획득
렉사리아 바이오사이언스, 디하이드라테크-CBD 조성물 및 디하이드라테크-세마글루타이드 모두 평가한 동물실험 GLP-1-A26-1 결과 발표···아쉽게도 뇌 조직 내 DHT-SEMA 농도는 본 연구에 사용된 생물학적 분석의 정량 하한선 이하 수준
Gainers 의료 관련 주식
 ESLA Estrella Immunopharma, Inc. - Common Stock | 0.54 | +68.75% |
 DRMA Dermata Therapeutics, Inc. - Common Stock | 0.91 | +37.88% |
 INDP Indaptus Therapeutics, Inc. - Common Stock | 2.85 | +28.96% |
 HUMA Humacyte, Inc. - Common Stock | 0.44 | +25.71% |
 NMRA Neumora Therapeutics, Inc. - Common Stock | 0.43 | +22.86% |
 PIIIW P3 Health Partners Inc. - Warrant | 0.0072 | +20.00% |
 TRIB Trinity Biotech plc - American Depositary Shares each represent | 7.93 | +19.97% |
 AKTX Akari Therapeutics Plc - American Depositary Shares | 8.67 | +19.75% |
Losers 의료 관련 주식
 SPRC SciSparc Ltd. - Ordinary Shares | 2.00 | -44.75% |
 CDIOW Cardio Diagnostics Holdings Inc. - Warrant | 0.0064 | -28.09% |
 NXGLW NexGel, Inc - Warrant | 0.0065 | -27.78% |
 DRTSW Alpha Tau Medical Ltd. - Warrant | 2.9900 | -17.40% |
 PFSA Profusa, Inc. - Common Stock | 1.07 | -16.41% |
 MDAIW Spectral AI, Inc. - Warrants | 0.4100 | -16.33% |
 CDTTW CDT Equity Inc. - Warrant | 0.0061 | -15.28% |
 PTN Palatin Technologies, Inc. Common Stock | 6.49 | -15.27% |